-
Something wrong with this record ?
Microbiota alteration at different stages in gastric lesion progression: a population-based study in Linqu, China
G. Kadeerhan, M. Gerhard, JJ. Gao, R. Mejías-Luque, L. Zhang, M. Vieth, JL. Ma, M. Bajbouj, S. Suchanek, WD. Liu, K. Ulm, M. Quante, ZX. Li, T. Zhou, R. Schmid, M. Classen, WQ. Li, Y. Zhang, WC. You, KF. Pan
Language English Country United States
Document type Journal Article
NLK
Free Medical Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
PubMed
33575087
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
In addition to Helicobacter pylori (H.pylori), gastric microbiota may be involved in carcinogenesis process. However, the longitudinal study to assess changes in the gastric microbiota associated with the development of gastric carcinogenesis is still limited. The aim of this study is to explore dynamic microbial alterations in gastric cancer (GC) development based on a 4-year endoscopic follow-up cohort in Linqu County, China. Microbial alterations were investigated by deep sequencing of the microbial 16S ribosomal RNA gene in 179 subjects with various gastric lesions, and validated in paired gastric biopsies prospectively collected before and after lesion progression and in non-progression controls. Significant differences were found in microbial diversity and community structure across various gastric lesions, with 62 candidate differential taxa between at least two lesion groups. Further validations identified Helicobacter, Bacillus, Capnocytophaga and Prevotella to be associated with lesion progression-to-dysplasia (DYS)/GC (all P < 0.05), especially for subjects progressing from intestinal metaplasia (IM) to DYS/GC. The combination of the four genera in a microbial dysbiosis index showed a significant difference after lesion progression-to-DYS/GC compared to controls (P = 0.027). The panel including the four genera identified subjects after progression-to-DYS/GC with an area under the receiver-operating curve (AUC) of 0.941. Predictive significance was found before lesion progression-to-DYS/GC with an AUC = 0.776 and an even better AUC (0.927) for subjects progressing from IM to DYS/GC. Microbiota may play different roles at different stages in gastric carcinogenesis. A panel of bacterial genera associated with gastric lesions may help to assess gastric microbial dysbiosis and show potential predictive values for lesion progression. Our findings provide new clues for the microbial mechanism of H.pylori-associated carcinogenesis.
2 Medizinische Klinik Klinikum Rechts der Isar Technische Universität München Munich Germany
German Center for Infection Research Partner Site Munich Munich Germany
Institute of Pathology Klinikum Bayreuth Bayreuth Germany
International Digestive Cancer Alliance Germany
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21010552
- 003
- CZ-PrNML
- 005
- 20210715153718.0
- 007
- ta
- 008
- 210413s2021 xxu f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)33575087
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kadeerhan, Gaohaer $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
- 245 10
- $a Microbiota alteration at different stages in gastric lesion progression: a population-based study in Linqu, China / $c G. Kadeerhan, M. Gerhard, JJ. Gao, R. Mejías-Luque, L. Zhang, M. Vieth, JL. Ma, M. Bajbouj, S. Suchanek, WD. Liu, K. Ulm, M. Quante, ZX. Li, T. Zhou, R. Schmid, M. Classen, WQ. Li, Y. Zhang, WC. You, KF. Pan
- 520 9_
- $a In addition to Helicobacter pylori (H.pylori), gastric microbiota may be involved in carcinogenesis process. However, the longitudinal study to assess changes in the gastric microbiota associated with the development of gastric carcinogenesis is still limited. The aim of this study is to explore dynamic microbial alterations in gastric cancer (GC) development based on a 4-year endoscopic follow-up cohort in Linqu County, China. Microbial alterations were investigated by deep sequencing of the microbial 16S ribosomal RNA gene in 179 subjects with various gastric lesions, and validated in paired gastric biopsies prospectively collected before and after lesion progression and in non-progression controls. Significant differences were found in microbial diversity and community structure across various gastric lesions, with 62 candidate differential taxa between at least two lesion groups. Further validations identified Helicobacter, Bacillus, Capnocytophaga and Prevotella to be associated with lesion progression-to-dysplasia (DYS)/GC (all P < 0.05), especially for subjects progressing from intestinal metaplasia (IM) to DYS/GC. The combination of the four genera in a microbial dysbiosis index showed a significant difference after lesion progression-to-DYS/GC compared to controls (P = 0.027). The panel including the four genera identified subjects after progression-to-DYS/GC with an area under the receiver-operating curve (AUC) of 0.941. Predictive significance was found before lesion progression-to-DYS/GC with an AUC = 0.776 and an even better AUC (0.927) for subjects progressing from IM to DYS/GC. Microbiota may play different roles at different stages in gastric carcinogenesis. A panel of bacterial genera associated with gastric lesions may help to assess gastric microbial dysbiosis and show potential predictive values for lesion progression. Our findings provide new clues for the microbial mechanism of H.pylori-associated carcinogenesis.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gerhard, Markus $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München Munich, Germany ; German Center for Infection Research, Partner Site Munich Munich, Germany
- 700 1_
- $a Gao, Juan-Juan $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a Mejías-Luque, Raquel $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München Munich, Germany ; German Center for Infection Research, Partner Site Munich Munich, Germany
- 700 1_
- $a Zhang, Lian $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a Vieth, Michael $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Pathology, Klinikum Bayreuth Bayreuth, Germany
- 700 1_
- $a Ma, Jun-Ling $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a Bajbouj, Monther $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; II. Medizinische Klinik, Klinikum Rechts der Isar, Technische Universität München Munich, Germany
- 700 1_
- $a Suchanek, Stepan $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Department of Medicine, 1st Faculty of Medicine, Military University Hospital, Charles University Prague, Czech Republic
- 700 1_
- $a Liu, Wei-Dong $u Linqu Public Health Bureau Linqu, Shandong, China
- 700 1_
- $a Ulm, Kurt $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München Munich, Germany
- 700 1_
- $a Quante, Michael $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; II. Medizinische Klinik, Klinikum Rechts der Isar, Technische Universität München Munich, Germany
- 700 1_
- $a Li, Zhe-Xuan $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a Zhou, Tong $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a Schmid, Roland $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; II. Medizinische Klinik, Klinikum Rechts der Isar, Technische Universität München Munich, Germany
- 700 1_
- $a Classen, Meinhard $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China ; International Digestive Cancer Alliance Germany
- 700 1_
- $a Li, Wen-Qing $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China $u PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a Zhang, Yang $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a You, Wei-Cheng $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
- 700 1_
- $a Pan, Kai-Feng $u Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute Beijing, China ; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München, Munich, Germany, Peking University Cancer Hospital & Institute Beijing, China
- 773 0_
- $w MED00188728 $t American journal of cancer research $x 2156-6976 $g Roč. 11, č. 2 (2021), s. 561-575
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33575087 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210413 $b ABA008
- 991 __
- $a 20210715153717 $b ABA008
- 999 __
- $a ind $b bmc $g 1649852 $s 1130928
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 2 $d 561-575 $e 20210201 $i 2156-6976 $m American journal of cancer research $n Am J Cancer Res $x MED00188728
- LZP __
- $a Pubmed-20210413